瘤抑制剂REST对雌激素受体 (ESR1) 的调节作用表达和瘤病理生理学
bioRxiv : the preprint server for biology
|September 5, 2025
概括
在子宫纤维瘤中失去REST会破坏雌激素和孕激素的信号传递. REST在表观遗传调节中的作用为新细胞培养方法和子宫瘤治疗提供了潜力.
科学领域:
- 生殖生物学
- 表观遗传学
- 分子内分泌学
背景情况:
- 大多数女性在50岁时患有子宫肌瘤 (纤维瘤),其病理生理不清楚.
- 目前的临床前模型和体外系统难以复制子宫瘤激素信号.
- 在培养的子宫光滑肌细胞中,雌激素受体α (ESR1) 和孕激素受体 (PGR) 的表达迅速丧失,这限制了研究.
研究的目的:
- 研究REST (沉默抑制剂) 在子宫瘤发育和激素受体调节中的作用.
- 确定REST影响ESR1和PGR表达的机制.
- 探索REST作为治疗点的潜力及其在子宫瘤表观遗传调节中的作用.
主要方法:
- 在小鼠模型和细胞培养中进行染色体免疫沉 (ChIP-PCR和ChIP-seq).
- 分析与ESR1和PGR基因组位点的REST关联.
- 调查PRICKLE1在REST中介的ESR1监管中的作用.
主要成果:
- REST直接与ESR1位点结合,通过表观基因调节其表达.
- 在小鼠模型中,REST的丧失对PGR目标基因产生全球影响,并改变ESR1位点的PGR结合.
- REST对ESR1的抑制与WNT通路分子PRICKLE1有关.
- 在培养细胞中静止ESR1的REST功能表明REST调制可能维持ESR1的表达.
结论:
- 在子宫瘤病理生理学中,REST是关键的表观遗传调节剂.
- 休息对维持正常的雌激素和孕激素信号通路起着至关重要的作用.
- REST调制为新型细胞培养技术和子宫瘤治疗干预措施提供了潜在的策略.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
MicroRNAs
21.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


